Relation of intraocular concentrations of inflammatory factors and improvement of macular edema after vitrectomy in branch retinal vein occlusion

American Journal of Ophthalmology

Volumn 151, Issue 4, 2011, Pages 610-616.e1

  Okunuki, Yoko ^a   Usui, Yoshihiko ^a   Katai, Naomichi ^a   Kezuka, Takeshi ^a   Takeuchi, Masaru ^a   Goto, Hiroshi ^a   Wakabayashi, Yoshihiro ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN; MONOKINE; VASCULOTROPIN;

AGED; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; INFLAMMATORY CELL; INTRAOCULAR PRESSURE; MALE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETINA MACULA EDEMA; VITRECTOMY; VITREOUS BODY;

EID: 79952991186     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2010.09.030     Document Type: Article

References (50)

1. D.V. Greer, I.J. Constable, and R.L. Cooper Macular oedema and retinal branch vein occlusion Aust J Ophthalmol 8 3 1980 207 209 (Pubitemid 11251129)
2. R.G. Michels, and J.D. Gass The natural course of retinal branch vein obstruction Trans Am Acad Ophthalmol Otolaryngol 78 2 1974 166 177
3. R.L. McIntosh, Q. Mohamed, S.M. Saw, and T.Y. Wong Interventions for branch retinal vein occlusion: an evidence-based systematic review Ophthalmology 114 5 2007 835 854
4. S.D. Chen, V. Sundaram, J. Lochhead, and C.K. Patel Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion Am J Ophthalmol 141 5 2006 876 883
5. The Branch Vein Occlusion Study Group Argon laser photocoagulation for macular edema in branch vein occlusion Am J Ophthalmol 98 3 1984 271 282
6. M. Battaglia Parodi, S. Saviano, L. Bergamini, and G. Ravalico Grid laser treatment of macular edema in macular branch retinal vein occlusion Doc Ophthalmol 97 34 1999 427 431
7. M. Battaglia Parodi, S. Saviano, and G. Ravalico Grid laser treatment in macular branch retinal vein occlusion Graefes Arch Clin Exp Ophthalmol 237 12 1999 1024 1027 (Pubitemid 30021293)
8. S.A. Pai, R. Shetty, and P.B. Vijayan Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion Am J Ophthalmol 143 4 2007 601 606
9. M. Kondo, N. Kondo, and Y. Ito Intravitreal injection of bevacizumab for macular edema secondary to branch retinal vein occlusion:results after 12 months and multiple regression analysis Retina 29 9 2009 1242 1248
10. A.A. Ahmadi, J.Y. Chuo, A. Banashkevich, P.E. Ma, and D.A. Maberley The effects of intravitreal bevacizumab on patients with macular edema secondary to branch retinal vein occlusion Can J Ophthalmol 44 2 2009 154 159
11. V. Russo, A. Barone, E. Conte, F. Prascina, A. Stella, and N.D. Noci Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion Retina 29 4 2009 511 515
12. F. Prager, S. Michels, and K. Kriechbaum Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial Br J Ophthalmol 93 4 2009 452 456
13. G.B. Jaissle, M. Leitritz, F. Gelisken, F. Ziemssen, K.U. Bartz-Schmidt, and P. Szurman One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion Graefes Arch Clin Exp Ophthalmol 247 1 2009 27 33
14. Y. Inomata, A. Hirata, E. Takahashi, T. Kawaji, M. Fukushima, and H. Tanihara Elevated erythropoietin in vitreous with ischemic retinal diseases Neuroreport 15 5 2004 877 879 (Pubitemid 38453478)
15. M. Funk, K. Kriechbaum, and F. Prager Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab Invest Ophthalmol Vis Sci 50 3 2009 1025 1032
16. T. Yoshimura, K.H. Sonoda, and M. Sugahara Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases PLoS One 4 12 2009 e8158
17. S.P. Park, and J.K. Ahn Changes of aqueous vascular endothelial growth factor and pigment epithelium-derived factor following intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion Clin Experiment Ophthalmol 37 5 2009 490 495
18. H. Noma, H. Funatsu, and M. Yamasaki Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion Eye (Lond) 22 1 2008 42 48
19. H. Noma, A. Minamoto, and H. Funatsu Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion Graefes Arch Clin Exp Ophthalmol 244 3 2006 309 315
20. H. Noma, H. Funatsu, and M. Yamasaki Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6 Am J Ophthalmol 140 2 2005 256 261
21. M. Arai, S. Yamamoto, Y. Mitamura, E. Sato, T. Sugawara, and S. Mizunoya Efficacy of vitrectomy and internal limiting membrane removal for macular edema associated with branch retinal vein occlusion Ophthalmologica 223 3 2009 172 176
22. T. Yamamoto, N. Akabane, and S. Takeuchi Vitrectomy for diabetic macular edema: the role of posterior vitreous detachment and epimacular membrane Am J Ophthalmol 132 3 2001 369 377 (Pubitemid 32768606)
23. M. Raszewska-Steglinska, P. Gozdek, S. Cisiecki, Z. Michalewska, J. Michalewski, and J. Nawrocki Pars plana vitrectomy with ILM peeling for macular edema secondary to retinal vein occlusion Eur J Ophthalmol 19 6 2009 1055 1062
24. K. Kumagai, M. Furukawa, N. Ogino, E. Larson, and A. Uemura Long-term visual outcomes after vitrectomy for macular edema with foveal hemorrhage in branch retinal vein occlusion Retina 27 5 2007 584 588 (Pubitemid 46905149)
25. X.L. Liang, H.Y. Chen, and Y.S. Huang Pars plana vitrectomy and internal limiting membrane peeling for macular oedema secondary to retinal vein occlusion: a pilot study Ann Acad Med Singapore 36 4 2007 293 297
26. R. Maier, M. Weger, and E.M. Haller-Schober Application of multiplex cytometric bead array technology for the measurement of angiogenic factors in the vitreous Mol Vis 12 2006 1143 1147 (Pubitemid 44509623)
27. R. Maier, M. Weger, and E.M. Haller-Schober Multiplex bead analysis of vitreous and serum concentrations of inflammatory and proangiogenic factors in diabetic patients Mol Vis 14 2008 637 643 (Pubitemid 351486723)
28. M. Yamasaki, H. Noma, and H. Funatsu Changes in foveal thickness after vitrectomy for macular edema with branch retinal vein occlusion and intravitreal vascular endothelial growth factor Int Ophthalmol 29 3 2009 161 167
29. S.M. Weis, and D.A. Cheresh Pathophysiological consequences of VEGF-induced vascular permeability Nature 437 7058 2005 497 504 (Pubitemid 41613541)
30. L.P. Aiello, J.M. Northrup, B.A. Keyt, H. Takagi, and M.A. Iwamoto Hypoxic regulation of vascular endothelial growth factor in retinal cells Arch Ophthalmol 113 12 1995 1538 1544
31. J.A. Belperio, M.P. Keane, and D.A. Arenberg CXC chemokines in angiogenesis J Leukoc Biol 68 1 2000 1 8
32. R.M. Strieter, P.J. Polverini, and S.L. Kunkel The functional role of the ELR motif in CXC chemokine-mediated angiogenesis J Biol Chem 270 45 1995 27348 27357
33. W.L. Biffl, E.E. Moore, F.A. Moore, V.S. Carl, R.J. Franciose, and A. Banerjee Interleukin-8 increases endothelial permeability independent of neutrophils J Trauma 39 1 1995 98 102
34. T. Fukumoto, A. Matsukawa, and T. Yoshimura IL-8 is an essential mediator of the increased delayed-phase vascular permeability in LPS-induced rabbit pleurisy J Leukoc Biol 63 5 1998 584 590 (Pubitemid 28193771)
35. V.M. Elner, R.M. Strieter, S.G. Elner, M. Baggiolini, I. Lindley, and S.L. Kunkel Neutrophil chemotactic factor (IL-8) gene expression by cytokine-treated retinal pigment epithelial cells Am J Pathol 136 4 1990 745 750 (Pubitemid 20142311)
36. Z.M. Bian, S.G. Elner, A. Yoshida, and V.M. Elner Differential involvement of phosphoinositide 3-kinase/Akt in human RPE MCP-1 and IL-8 expression Invest Ophthalmol Vis Sci 45 6 2004 1887 1896 (Pubitemid 38868986)
37. V.M. Elner, S.G. Elner, T.J. Standiford, N.W. Lukacs, R.M. Strieter, and S.L. Kunkel Interleukin-7 (IL-7) induces retinal pigment epithelial cell MCP-1 and IL-8 Exp Eye Res 63 3 1996 297 303 (Pubitemid 26325119)
38. M.V. Kumar, C.N. Nagineni, M.S. Chin, J.J. Hooks, and B. Detrick Innate immunity in the retina: Toll-like receptor (TLR) signaling in human retinal pigment epithelial cells J Neuroimmunol 153 12 2004 7 15 (Pubitemid 38950922)
39. S. Yoshida, A. Yoshida, and T. Ishibashi Induction of IL-8, MCP-1, and bFGF by TNF-alpha in retinal glial cells: implications for retinal neovascularization during post-ischemic inflammation Graefes Arch Clin Exp Ophthalmol 242 5 2004 409 413 (Pubitemid 38801529)
40. I.J. Crane, C.A. Wallace, S. McKillop-Smith, and J.V. Forrester Control of chemokine production at the blood-retina barrier Immunology 101 3 2000 426 433
41. M. Loetscher, B. Gerber, and P. Loetscher Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes J Exp Med 184 3 1996 963 969
42. J.M. Farber HuMig: a new human member of the chemokine family of cytokines Biochem Biophys Res Commun 192 1 1993 223 230 (Pubitemid 23205290)
43. P. Romagnani, E. Lazzeri, and L. Lasagni IP-10 and Mig production by glomerular cells in human proliferative glomerulonephritis and regulation by nitric oxide J Am Soc Nephrol 13 1 2002 53 64 (Pubitemid 34042011)
44. A. Egesten, M. Eliasson, and H.M. Johansson The CXC chemokine MIG/CXCL9 is important in innate immunity against Streptococcus pyogenes J Infect Dis 195 5 2007 684 693
45. A.V. Gorbachev, H. Kobayashi, and D. Kudo CXC chemokine ligand 9/monokine induced by IFN-gamma production by tumor cells is critical for T cell-mediated suppression of cutaneous tumors J Immunol 178 4 2007 2278 2286 (Pubitemid 46233426)
46. R. Zhang, L. Tian, and L.J. Chen Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma Gene Ther 13 17 2006 1263 1271 (Pubitemid 44264080)
47. P. Ghersa, M. Gelati, and J. Colinge MIGdifferential gene expression in mouse brain endothelial cells Neuroreport 13 1 2002 9 14 (Pubitemid 34102018)
48. Y. Wakabayashi, Y. Usui, and Y. Okunuki Increased levels of monokine induced by interferon-gamma (Mig) in the vitreous of patients with diabetic retinopathy Diabet Med 25 7 2008 875 877
49. M.L. Petreaca, M. Yao, Y. Liu, K. Defea, and M. Martins-Green Transactivation of vascular endothelial growth factor receptor-2 by interleukin-8 (IL-8/CXCL8) is required for IL-8/CXCL8-induced endothelial permeability Mol Biol Cell 18 12 2007 5014 5023 (Pubitemid 350246701)
50. M. Li, Y. Zhang, and L.W. Feurino Interleukin-8 increases vascular endothelial growth factor and neuropilin expression and stimulates ERK activation in human pancreatic cancer Cancer Sci 99 4 2008 733 737 (Pubitemid 351448077)